1422 / 1544
•
ESMO Clinical Practice Guidelines 2013: SABR is the
non surgical treatment of choice (dose to a biologically
equivalent tumor dose > 100 Gy)
•
NCCN guidelines (version 3.2014): non surgical
treatment of choice
SABR for peripheral lung tumors